key: cord-0759134-4py3s44v
authors: Kang, Yu Min; Park, Noh Hyuck; Seong, Min Jae; Han, Hyun Jeong; Jung, Young Hee
title: Multiple Enhanced Lesions in the Brain MRI of a Patient with COVID-19
date: 2021-04-08
journal: Dement Neurocogn Disord
DOI: 10.12779/dnd.2021.20.2.13
sha: db94f3615d376d9fdb8188ce3385b4111d018f60
doc_id: 759134
cord_uid: 4py3s44v

nan

To evaluate the cardiac source of emboli, transthoracic echocardiography was performed. There was no evidence of embolic sources such as infective endocarditis. To evaluate vasculitis, additional laboratory tests were performed. Serologic testing revealed negative fluorescent antinuclear and p-type antineutrophil cytoplasmic antibodies through a serum immunofluorescence test. Enzyme-linked immunosorbent assay revealed negative myeloperoxidase and peroxidase-3 antibodies. Cerebrospinal fluid studies on the 48th day showed an increased red blood cell level count (234/μL). Otherwise, the composition of cerebral fluids and the opening pressure were normal. No specific rheumatologic diagnoses were made because the patient did not present any systemic manifestations such as skin lesions, arthritis, or signs of small vessel vasculitis except for the brain MRI finding. Steroid pulse was not considered due to his severe pneumonia, and intravenous immunoglobulin was not administered due to his unstable vital signs. On the 52nd day, he died due to the progression of pneumonia and shock, which did not respond to vasopressors.

The radiologic findings in our patient might suggest that small intracranial vessels were involved in COVID-19-associated vasculitis in that punctate and patchy enhancements have been reported as characteristic of vasculitis. [1] [2] [3] In addition, scattered enhanced lesions with hemorrhages were not uncommon findings on the MRIs of multiple embolic infarctions. COVID-19-associated neurologic complications involving the central nervous system (CNS) have also been reported, including acute hemorrhagic necrotizing encephalopathy and CNSvasculitis. [2] [3] [4] [5] The previous CNS-vasculitis case was considered as a result of the endothelial injury caused by the binding of SARS-CoV-2 to angiotensin converting enzyme-2. However, a delayed immune reaction, and not SARS-CoV-2 infection, may have caused multiple brain lesions in our case. The patient's consciousness deteriorated approximately a month later, and MRI showed a finding resembling CNS-vasculitis, although the patient was released from quarantine after he tested negative for COVID-19 on the 25th day.

Furthermore, the asymmetric pattern that characterised the case of our patient was different from the symmetric pattern of the brain lesions on the MRI in a previously reported case of acute hemorrhagic necrotizing encephalopathy. In addition, we suspected the possibility of subacute stroke was caused by multiple emboli migrating to left middle cerebral artery territory. However, diffusion-MRI on the 25th day and 42nd day showed no abnormal findings.

The limitation is that diagnostic uncertainty remains. Brain imaging is the only evidence to support CNS-vasculitis and the diagnostic criteria of primary angiitis of the CNS were not satisfied. The possibility of cerebral infarct cannot be excluded, despite no evidence of cardiac embolism and consecutive, negative diffusion-MRI. Brain-biopsy, detailed neurologic exams and studies including other vasculitis markers, cytokines and complement fraction should be followed to confirm the diagnosis in future studies.

In conclusion, a neurologic complication with multiple enhanced lesions in brain MRIs may be present in patients with COVID-19.

Punctate pattern: a promising imaging marker for the diagnosis of natalizumab-associated PML

COVID-19 neurologic complication with CNS vasculitis-like pattern

Cerebral nervous system vasculitis in a COVID-19 patient with pneumonia

COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study